These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22380695)
1. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling. Mustonen E; Ruskoaho H; Rysä J Ann Med; 2012 Dec; 44(8):793-804. PubMed ID: 22380695 [TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609 [TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy. Novoyatleva T; Janssen W; Wietelmann A; Schermuly RT; Engel FB Cytokine; 2013 Oct; 64(1):43-5. PubMed ID: 23764551 [TBL] [Abstract][Full Text] [Related]
4. TWEAK and Fn14: new molecular targets for cancer therapy? Winkles JA; Tran NL; Berens ME Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893 [TBL] [Abstract][Full Text] [Related]
5. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561 [TBL] [Abstract][Full Text] [Related]
6. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112 [TBL] [Abstract][Full Text] [Related]
7. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961 [TBL] [Abstract][Full Text] [Related]
8. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630 [TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157 [TBL] [Abstract][Full Text] [Related]
10. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis. Chen J; Wei L; Xia Y Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa). Shui Y; Guan ZB; Zhang SQ Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982 [TBL] [Abstract][Full Text] [Related]
13. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis. Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741 [TBL] [Abstract][Full Text] [Related]
14. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776 [TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway. Wang D; Fung JN; Tuo Y; Hu L; Chen C Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297 [TBL] [Abstract][Full Text] [Related]
16. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Jain M; Jakubowski A; Cui L; Shi J; Su L; Bauer M; Guan J; Lim CC; Naito Y; Thompson JS; Sam F; Ambrose C; Parr M; Crowell T; Lincecum JM; Wang MZ; Hsu YM; Zheng TS; Michaelson JS; Liao R; Burkly LC Circulation; 2009 Apr; 119(15):2058-68. PubMed ID: 19349318 [TBL] [Abstract][Full Text] [Related]
17. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells. Chen DY; Su GF Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050952 [TBL] [Abstract][Full Text] [Related]
19. TWEAK is a positive regulator of cardiomyocyte proliferation. Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380 [TBL] [Abstract][Full Text] [Related]
20. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities. Burkly LC Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]